We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6856:TSEHoriba , Ltd. Analysis

Data as of 2026-08-20 - not real-time

¥23,655.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind HORIBA, Ltd. is neutral at ¥23,655.00, with no clear ordering between short and long averages. Over a rolling month the price has lost 10.3%. RSI sits at 40.2, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at ¥22,930.00 and resistance at ¥28,315.00.
On valuation the read is undervalued — earnings multiple of 22.9 versus a 35.2 sector average, below the peer group. The average analyst target implies 25.6% above today's level. Revenue is growing at 23.7% on a 11.8% profit margin. The 1.52% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 65.3%, a beta of 1.10 and a maximum drawdown of 19.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.

Top Market Events

Detailed price information for Horiba Ltd Ord HRIBF from The Globe and Mail including charting and trades.HORIBA TSE:6856 has announced a sharp increase to its full-year dividend.Detailed price information for Horiba Ltd Ord HRIBF from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 20739.08
  • MACD momentum is negative
  • 30-day price change of -10.3%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 22.9 versus sector average of 35.2
  • Trading above the 200-day average of 20739.08
  • Analyst targets imply +25.6% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 22.9 versus sector average of 35.2
  • Analyst targets imply +25.6% versus the current price
  • Revenue growth of +23.7%

Key Metrics & Analysis

Financial Health

Revenue Growth23.70%
Profit Margin11.82%
P/E Ratio22.9
ROE12.68%
ROA7.54%
Debt/Equity17.22
P/B Ratio2.7
Op. Cash Flow¥57.9B
Free Cash Flow¥20.9B
Industry P/E35.2

Technical Analysis

TrendNeutral
RSI40.2
Support¥22,930.00
Resistance¥28,315.00
MA 20¥25,438.00
MA 50¥26,517.50
MA 200¥20,739.08
MACDBearish
VolumeStable
Fear & Greed Index92.84

Valuation

Fair Value¥19,224.87
Target Price¥29,714.29
Upside/Downside25.62%
GradeUndervalued
TypeBlend
Dividend Yield1.52%

Risk Assessment

Beta1.10
Volatility65.32%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.